The comparison between topical terbinafine and placebo in the treatment of cutaneous leishmaniasis

Phase 1

Recruiting

• Conditions: cutaneou leishmaniasis; Skin - Dermatological conditions

• Registration Number: ACTRN12609000113257
• Lead Sponsor: Kerman medical university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-02-18
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

age>2 years, the size of lesion<3cm, the number of lesions<4, the patients whom did not injected glucantim, the patinets whom did not receive any treatment for leishmaniasis within last month.

Exclusion Criteria

pregnancy, lactation, the lesions of articular area.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
size of induration with a transparent paper by an independed observer who is blind to the treatment options[the size of induration will be measures every 2 weeks week up to 10 weeks, 2 weeks and 3 months after the end of treatment]

Secondary Outcome Measures

Name	Time	Method
smear for leishman body[at the end of treatment, 2 weeks and 3 months after the end of treatment]